Carl O’Hara

7.6k total citations · 2 hit papers
108 papers, 5.8k citations indexed

About

Carl O’Hara is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Carl O’Hara has authored 108 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 33 papers in Oncology and 22 papers in Immunology. Recurrent topics in Carl O’Hara's work include Amyloidosis: Diagnosis, Treatment, Outcomes (33 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Lymphoma Diagnosis and Treatment (11 papers). Carl O’Hara is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (33 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Lymphoma Diagnosis and Treatment (11 papers). Carl O’Hara collaborates with scholars based in United States, Switzerland and United Kingdom. Carl O’Hara's co-authors include David C. Seldin, Martha Skinner, Vaishali Sanchorawala, John L. Berk, Rodney H. Falk, Daniel G. Wright, Niall Swan, Jerome E. Groopman, Elliott Kieff and Lawrence S. Young and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Carl O’Hara

108 papers receiving 5.6k citations

Hit Papers

HTLV-III Infection in Brains of Children and Adults with ... 1985 2026 1998 2012 1985 1989 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl O’Hara United States 36 2.3k 1.8k 1.0k 1.0k 943 108 5.8k
Giovanni Barillari Italy 35 1.5k 0.7× 2.0k 1.2× 1.2k 1.1× 1.1k 1.1× 1000 1.1× 141 6.0k
Akifumi Takaori‐Kondo Japan 42 2.3k 1.0× 1.2k 0.7× 861 0.8× 1.9k 1.8× 323 0.3× 288 5.8k
D Émilie France 38 579 0.3× 982 0.6× 950 0.9× 2.2k 2.2× 445 0.5× 92 5.5k
Alberto Amadori Italy 34 1.5k 0.7× 1.3k 0.7× 418 0.4× 1.3k 1.3× 342 0.4× 108 4.0k
Yuji Ohtsuki Japan 36 1.7k 0.7× 1.4k 0.8× 858 0.8× 1.9k 1.9× 687 0.7× 263 5.9k
Patricia L. Myskowski United States 33 710 0.3× 1.9k 1.1× 1.7k 1.6× 1.2k 1.2× 1.7k 1.8× 152 4.9k
Cecilia Sgadari Italy 29 1.3k 0.6× 2.2k 1.3× 562 0.5× 1.6k 1.6× 540 0.6× 68 4.2k
Jay H. Beckstead United States 30 1.0k 0.5× 1.1k 0.6× 356 0.3× 759 0.8× 792 0.8× 67 4.5k
Riccardo Dolcetti Italy 48 1.6k 0.7× 4.8k 2.7× 1.4k 1.3× 2.1k 2.1× 3.2k 3.4× 255 8.3k
Guy Gorochov France 42 979 0.4× 1.5k 0.8× 807 0.8× 4.7k 4.7× 455 0.5× 111 7.4k

Countries citing papers authored by Carl O’Hara

Since Specialization
Citations

This map shows the geographic impact of Carl O’Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl O’Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl O’Hara more than expected).

Fields of papers citing papers by Carl O’Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl O’Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl O’Hara. The network helps show where Carl O’Hara may publish in the future.

Co-authorship network of co-authors of Carl O’Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Carl O’Hara. A scholar is included among the top collaborators of Carl O’Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl O’Hara. Carl O’Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millien, Guetchyn, Yuxia Cao, Carl O’Hara, et al.. (2018). ETS1 regulates Twist1 transcription in a KrasG12D/Lkb1−/− metastatic lung tumor model of non-small cell lung cancer. Clinical & Experimental Metastasis. 35(3). 149–165. 11 indexed citations
2.
Gower, Adam C., Praveen Sridhar, Anita Deshpande, et al.. (2017). miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma. Journal of Thoracic and Cardiovascular Surgery. 154(2). 714–727. 15 indexed citations
3.
Sloan, J. Mark, et al.. (2016). Extranodal Marginal Zone Endobronchial Lymphoma Associated With Hepatitis C. The Annals of Thoracic Surgery. 102(5). e407–e408. 3 indexed citations
4.
Girnius, Saulius, Martha Skinner, Brian Spencer, et al.. (2012). A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid. 19(4). 182–185. 19 indexed citations
6.
Rosenzweig, Michael, Heather Landau, David C. Seldin, et al.. (2012). Cancer-testis antigen expression and immunogenicity in AL amyloidosis. Blood Cancer Journal. 2(9). e90–e90. 7 indexed citations
7.
Cowan, A J, M Skinner, David C. Seldin, et al.. (2012). Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 98(1). 141–146. 118 indexed citations
8.
Charlot, Marjory, David C. Seldin, Carl O’Hara, Martha Skinner, & Vaishali Sanchorawala. (2011). Localized amyloidosis of the breast: a case series. Amyloid. 18(2). 72–75. 36 indexed citations
9.
Spencer, Brian, et al.. (2011). Dysregulation of miRNAs in AL amyloidosis. Amyloid. 18(3). 128–135. 7 indexed citations
10.
Ward, Jennifer E., et al.. (2011). Preclinical development of siRNA therapeutics for AL amyloidosis. Gene Therapy. 18(12). 1150–1156. 25 indexed citations
11.
Roehrl, Michael H. A., et al.. (2010). Eosinophilic myocarditis in hypereosinophilic syndrome. American Journal of Hematology. 86(7). 607–608. 12 indexed citations
12.
Connors, Lawreen H., Tatiana Prokaeva, Amareth Lim, et al.. (2009). Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. American Heart Journal. 158(4). 607–614. 99 indexed citations
13.
Horan, Gerald, Susan Wood, Victor Ona, et al.. (2007). Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. American Journal of Respiratory and Critical Care Medicine. 177(1). 56–65. 331 indexed citations
14.
Seldin, David C., Élie Choufani, Laura M. Dember, et al.. (2003). Tolerability and Efficacy of Thalidomide for the Treatment of Patients with Light Chain–Associated (AL) Amyloidosis. Clinical Lymphoma. 3(4). 241–246. 106 indexed citations
15.
Andrews, Charles W., J. Milburn Jessup, Harvey Goldman, et al.. (1993). Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon. Cancer. 72(11). 3185–3190. 19 indexed citations
16.
Loda, Massimo, Arturo Mendoza, Carl O’Hara, et al.. (1991). Well-differentiated hepatocellular carcinoma associated with long-term survival. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 418(6). 551–556. 1 indexed citations
17.
Sytkowski, Arthur J., Carl O’Hara, Gary Vanasse, et al.. (1990). Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.. Journal of Clinical Investigation. 85(1). 40–46. 16 indexed citations
18.
Young, Lawrence S., Caroline Alfieri, Kathleen Hennessy, et al.. (1989). Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease. New England Journal of Medicine. 321(16). 1080–1085. 660 indexed citations breakdown →
20.
Bernal, Samuel D., et al.. (1988). Membrane antigens of human bronchial epithelial cells identified by monoclonal antibodies. In Vitro Cellular & Developmental Biology - Plant. 24(2). 117–125. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026